In a previous clinical trial of i.c.v. infused IL13Rα2-targeted CAR T cells (19) and i.v. infused Her2-specific CAR-modified virus-specific T cells (VSTs) (25), efficacy of CAR T cells to multifocal brain tumors was observed. Here, IL13RA2 is linked to brain neoplasm.